|
|
Download our White Paper: Developing the High-Performance Medical Affairs Function
Clients and Partners:
- 3M Pharmaceuticals
- Abbott Laboratories
- Allergan
- Amgen
- AstraZeneca
- Aventis
- BASF
- Baxter
- Bayer
- Biogen
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Chiron
- Eisai
- Eli Lilly and Company
- Forest Laboratories
- Galderma
- Genentech
- GlaxoSmithKline
- Hoffmann-La Roche
- Janssen Pharmaceutica
- Johnson & Johnson
- Medtronic
- Merck
- Millennium Pharmaceuticals
- Monsanto
- Novartis
- Novo Nordisk
- Ortho Biotech
- Philips Medical Systems
- Pfizer
- Purdue
- Roche
- Sankyo Pharma
- Solvay Pharmaceuticals
- Takeda
- Tap Pharmaceuticals
- Vertex Pharmaceuticals
|
Medical Affairs: Research & Consulting
The best medical affairs functions can dramatically enhance a company’s scientific reputation by providing critical scientific/medical information and education to healthcare professionals, key opinion leaders and payer groups.
Best Practices, LLC’s Medical Affairs benchmarking Research & Consulting services provide you with the expertise and intelligence needed to develop a best-in-class Medical Affairs organizations by providing you access to benchmarks and best practices that:
- Drive efficiency and performance by setting the right structure, staffing, budget, spend, activity and performance measures
- Improve productivity and effectiveness through benchmarking key processes, systems and initiatives
- Highlight upcoming trends, key challenges and lessons learned
Specific examples of research conducted for medical affairs, include:
- Medical Affairs
- Building best-in-class capabilities for Medical Affairs
- Pharmaceutical New Product Planning: Role and Activities for Medical Affairs
- Health Economics/Outcomes
- HOL group structure and activities, role differentiation, customer engagement, and future trends
- How the HOL function drives value across the healthcare industry
- Medical Education
- Professional Medical Education structures, resources, services & performance levels to optimize pharmaceutical biotechnology and medical device education groups
- Educating KOLs, physicians, patients and payers to support successful product launches across specific therapeutic areas
- Medical Science Liaisons
- Generating value for diverse customer groups
- Gaining access and forging relationships with Key Opinion Leaders
- Scientific Publications
- Strategy for managing reputation, clinical trial results and commercial relevance
- Thought Leader (KOL) Relationship Management
- Optimizing Key Opinion Leader relationships
For more information on how we can support you in driving medical affairs excellence, please contact:
Cameron Tew, Executive Director of Research, Publishing, Marketing and Advisory Services
(919) 403-0251 ext. 246
Email Click Here
|